Neuropathologic and Neurochemical Correlates of Psychosis in Primary Dementia

Archives of Neurology

Volumn 48, Issue 6, 1991, Pages 619-624

  Zubenko, George S ^a   Moossy, John ^a   Martinez, A Julio ^a   Rao, Gutti ^a   Claassen, Diana ^a   Rosen, Jules ^a   Kopp, Ursula ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE ACETYLTRANSFERASE; NORADRENALIN; SEROTONIN;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; CLINICAL ARTICLE; DEMENTIA; FEMALE; HUMAN; MALE; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; PSYCHOSIS; SENILE PLAQUE; SUBSTANTIA NIGRA;

AGED; ALZHEIMER DISEASE; CEREBRAL CORTEX; FEMALE; HUMAN; HYDROXYINDOLEACETIC ACID; MALE; NEUROFIBRILS; NOREPINEPHRINE; PSYCHOTIC DISORDERS; SEROTONIN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025782754     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.1991.00530180075020     Document Type: Article

References (43)

1. Alzheimer A. Uber eine eigenartige Erkrankung der Hirnrinde. Allemmeine Zeitschr Psychiatr Psychisch-Gericht Med. 1907;64:146-148.
2. Wragg RE, Jeste DV. Overview of depression and psychosis in Alzheimer's disease. Am J Psychiatry. 1989;146:577-587.
3. Drevets WC, Rubin EH. Psychotic symptoms and the longitudinal course of senile dementia of the Alzheimer type. Biol Psychiatry. 1989;25:39-48.
4. Rosen J, Zubenko GS. Emergence of psychosis and depression in the longitudinal evaluation of Alzheimer's disease. Biol Psychiatry. 1991;29:224-232.
5. Stern Y, Mayeux R, Sano M, Hauser WA, Bush T. Predictors of disease course in patients with probable Alzheimer's disease. Neurology. 1987;37:1649-1653.
6. Zubenko GS, Moossy J. Major depression in primary dementia: clinical and neuropathologic correlates. Arch Neurol. 1988;45:1182-1186.
7. Zweig RM, Ross CA, Hedreen JC, et al. The neuropathology of aminergic nuclei in Alzheimer's disease. Ann Neurol. 1988;24:233-242.
8. Lopez OL, Boller F, Becker JT, Miller M, Reynolds CF. Alzheimer's disease and depression: neuropsychological impairment and progression of the illness. Am J Psychiatry. 1990;147:855-860.
9. Ingvar DH, Franzen G. Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia. Acta Psychiatr Scand. 1974;50:425-462.
10. Ariel RN, Golden CJ, Berg RA, et al. Regional cerebral blood flow in schizophrenics. Arch Gen Psychiatry. 1983;40:258-263.
11. Chabrol H, Guell A, Bes A, Moron P. Cerebral blood flow in schizophrenic adolescents. Am J Psychiatry. 1986;143:130.
12. Weingerg DR, Berman KF, Zec RF. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. Arch Gen Psychiatry. 1986;43:114-124.
13. Buchsbaum MS, Ingvar DH, Kessler R, et al. Cerebral glucography with positron tomography. Arch Gen Psychiatry. 1982;39:251-259.
14. Buchsbaum MS, DeLisi LE, Holcomb HH, et al. Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorders. Arch Gen Psychiatry. 1984;41:1159-1166.
15. Wolkin A, Jaeger J, Brodie JD, et al. Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography. Am J Psychiatry. 1985;142:564-571.
16. Kling AS, Metter EJ, Riege WH, Kuhl DE. Comparison of PET measurement of local brain glucose metabolism and CAT measurement of brain atrophy in chronic schizophrenia and depression. Am J Psychiatry. 1986;143:175-180.
17. Kovelman JA, Schiebel AB. A neurohistological correlate of schizophrenia. Biol Psychiatry. 1984;19:1601-1621.
18. Benes FM, Davidson J, Bird ED. Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics. Arch Gen Psychiatry. 1986;43:31-135.
19. Altschuler LL, Conrad A, Kovelman JA, Schiebel AB. Hippocampal pyramidal cell orientation of schizophrenia. Arch Gen Psychiatry. 1987;44:1094-1098.
20. Benes FM, Majocha R, Bird ED, Marotta CA. Increased cervical axon numbers in cingulate cortex of schizophrenics. Arch Gen Psychiatry. 1987;44:1017-1021.
21. Christison GW, Casanova MF, Weinberg DR, Rawlings R, Kleinman JE. A quantitative investigation of hippocampal pyramidal cell size, shape, and variability of orientation in schizophrenia. Arch Gen Psychiatry. 1989;46:1027-1032.
22. Jeste DV, Lohr JB. Hippocampal pathologic findings in schizophrenia: a morphometric study. Arch Gen Psychiatry. 1989;46:1019-1024.
23. Zubenko GS, Moossy J, Kopp U. Neurochemical correlates of major depression in primary dementia. Arch Neurol. 1990;47:209-214.
24. McKhann G, Brachman D, Folstein M, Katzman R, Price D, Stadlan E. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Task Force of Alzheimer's disease. Neurology. 1984;34:939-944.
25. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders-Revised. 3rd ed. Washington, DC: American Psychiatric Association; 1987.
26. Zubenko GS, Cohen BM, Reynolds CF, Boiler F, Malinakova I, Keefe N. Platelet membrane fluidity in Alzheimer's disease and major depression. Am J Psychiatry. 1987;144:860-868.
27. Huff FJ, Becker JT, Belle SH, Nebes RD, Holland AL, Boiler F. Cognitive deficits and clinical diagnosis of Alzheimer's disease. Neurology. 1987;37:1119-1124.
28. Huff FJ, Boller F, Lucchelli F, Querriera R, Beyer J, Belle S. The neurologic examination in patients with probable Alzheimer's disease. Arch Neurol. 1987;44:929-932.
29. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol. 1985;42:1097-1105.
30. Mezzich JE, Dow JT, Rich CL, Costello AJ, Himmelhoch JM. Developing an efficient clinical information system for a comprehensive psychiatric institute, II: initial evaluation form. Behav Res Meth Instrument. 1981;13:464-478.
31. Mezzich JE, Fabrega H, Coffman GA, Glavin YFG. Comprehensively diagnosing geriatric patients. Comp Psychiatry. 1987;28:68-76.
32. Mezzich JE, Fabrega H, Coffman GA, Haley R. DSM-III disorders in a large sample of psychiatric patients: frequency and specificity of diagnoses. Am J Psychiatry. 1989;146:212-219.
33. Moossy J, Zubenko GS, Martinez AJ, Rao GR. Bilateral symmetry of morphologic lesions in Alzheimer's disease. Arch Neurol. 1988;45:251-254.
34. Zubenko GS, Moossy J, Hanin I, Martinez AJ, Rao GR, Kopp U. Bilateral symmetry of cholinergic deficits in Alzheimer's disease. Arch Neurol. 1988;45:255-259.
35. Saller CF, Salama AI. Rapid automated analysis of biogenic amines and their metabolites using reversed-phase high performance liquid chromatography with electrochemical detections. J Chromatogr. 1984;309:287-298.
36. Zubenko GS, Moossy J, Kopp U. Neurochemical correlates of major depression in primary dementia. Arch Neurol. 1990;47:209-214.
37. Palmer AM, Francis PT, Bowen DM, et al. Catecholaminergic neurons assessed antemortem in Alzheimer's disease. Brain Res. 1987;414:365-375.
38. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
39. Fonnum F. Radiochemical micro assays for the determination of choline acetyltransferase and acetylcholinesterase activity. Biochem J. 1969;115:465-472.
40. Zubenko GS, Moossy J, Claassen D, Martinez AJ, Rao GR. Brain regional analysis of NADH-cytochrome C reductase activity in Alzheimer's disease. J Neuropathol Exp Neurol. 1990;49:206-214.
41. Zubenko GS. Biological correlates of clinical heterogeneity in primary dementia. Neuropsychopharmacology. In press.
42. Rovner BW, Broadhead J, Spencer M, Carson K, Folstein MF. Depression and Alzheimer's disease. Am J Psychiatry. 1989;146:350-354.
43. Hoch CC, Reynolds CF, Houck PR, et al. REM latency and apnea-hypopnea index predict two-year mortality in mixed depressed-demented patients. J Neuropsychiatr Clin Neurol. In press.